Copper-mediated radiochemistry: historical impact, current trends, and future possibilities.

npj Imaging Pub Date : 2025-06-10 eCollection Date: 2025-01-01 DOI:10.1038/s44303-025-00087-x
Gregory D Bowden, Marius Müller, Matthias M Herth, Melanie S Sanford, Peter J H Scott
{"title":"Copper-mediated radiochemistry: historical impact, current trends, and future possibilities.","authors":"Gregory D Bowden, Marius Müller, Matthias M Herth, Melanie S Sanford, Peter J H Scott","doi":"10.1038/s44303-025-00087-x","DOIUrl":null,"url":null,"abstract":"<p><p>Modern approaches to copper-mediated radiolabeling have proven an important addition to the radiochemical toolbox. Radiopharmaceuticals prepared using this methodology have been translated from preclinical PET studies into clinical trials, and it has been adapted for radionuclides beyond fluorine-18, enabling theranostic applications. The methodology is also beginning to benefit from AI-assisted radiochemistry development. This perspective discusses the history, state-of-the-art, and potential future impact of copper-mediated radiochemistry on radiopharmaceutical development.</p>","PeriodicalId":501709,"journal":{"name":"npj Imaging","volume":"3 ","pages":"25"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12151854/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"npj Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s44303-025-00087-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Modern approaches to copper-mediated radiolabeling have proven an important addition to the radiochemical toolbox. Radiopharmaceuticals prepared using this methodology have been translated from preclinical PET studies into clinical trials, and it has been adapted for radionuclides beyond fluorine-18, enabling theranostic applications. The methodology is also beginning to benefit from AI-assisted radiochemistry development. This perspective discusses the history, state-of-the-art, and potential future impact of copper-mediated radiochemistry on radiopharmaceutical development.

铜介导的放射化学:历史影响、当前趋势和未来可能性。
铜介导的放射性标记的现代方法已被证明是放射化学工具箱的重要补充。使用这种方法制备的放射性药物已从临床前PET研究转化为临床试验,并已适用于氟-18以外的放射性核素,从而实现治疗应用。该方法也开始受益于人工智能辅助放射化学的发展。这一观点讨论了铜介导的放射化学对放射性药物发展的历史、现状和潜在的未来影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信